De Smedt H, Missiaen L, Parys J B, Henning R H, Sienaert I, Vanlingen S, Gijsens A, Himpens B, Casteels R
Laboratory of Physiology, Campus Gasthuisberg O/N, K.U. Leuven, Belgium.
Biochem J. 1997 Mar 1;322 ( Pt 2)(Pt 2):575-83. doi: 10.1042/bj3220575.
Previous reports suggested the expression of four or five different Ins(1,4,5)P3 receptor [Ins(1,4,5)P3R] isoforms in mouse cells [Ross, Danoff, Schell, Snyder and Ullrich (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 4265-4269; De Smedt, Missiaen, Parys, Bootman, Mertens, Van Den Bosch and Casteels (1994) J. Biol. Chem. 269, 21691-21698]. To explore this diversity further, we have isolated and sequenced partial clones of two Ins(1,4,5)P3R mRNAs from the mouse embryonic C3H10T1/2 cell line. These clones showed between 94.2 and 94.9% sequence identity with the corresponding rat Ins(1,4,5)P3R-II and Ins(1,4,5)P3R-III isoforms. Based on these newly obtained sequences we have determined the relative expression of the different Ins(1,4,5)P3R mRNAs in cultured cells and in animal tissues of mouse origin by a ratio reverse transcriptase polymerase chain reaction (RT-PCR). Ins(1,4,5)P3R-I was very prominent in brain and cerebellum and Ins(1,4,5)P3R-II in epithelia such as kidney as well as in both cardiac and skeletal muscle. Ins(1,4,5)P3R-III was highly expressed in all cultured cell types and in tissues with high cell turnover, e.g. testis. The prominent expression of Ins(1,4,5)P3R-I and Ins(1,4,5)P3R-III in A7r5 and C3H10T1/2 cells respectively was confirmed by immunoblot analysis and was compatible with a lower threshold for Ins(1,4,5)P3-induced Ca2+ release in the former cell type. Screening of a large number of mouse cell lines and tissues revealed the presence of Ins(1,4,5)P3R-I as well as of the Ins(1,4,5)P3R-II and Ins(1,4,5)P3R-III isoforms which were identified in the present study, but in contrast with previous reports there was no evidence for more isoform diversity.
先前的报告表明,小鼠细胞中存在四种或五种不同的1,4,5-三磷酸肌醇受体[Ins(1,4,5)P3R]亚型[罗斯、达诺夫、谢尔、斯奈德和乌尔里希(1992年)《美国国家科学院院刊》89, 4265 - 4269;德·斯梅特、米西亚恩、帕里斯、博特曼、默滕斯、范登博施和卡斯特尔斯(1994年)《生物化学杂志》269, 21691 - 21698]。为了进一步探究这种多样性,我们从小鼠胚胎C3H10T1/2细胞系中分离并测序了两种Ins(1,4,5)P3R mRNA的部分克隆。这些克隆与相应的大鼠Ins(1,4,5)P3R-II和Ins(1,4,5)P3R-III亚型的序列同一性在94.2%至94.9%之间。基于这些新获得的序列,我们通过比率逆转录聚合酶链反应(RT-PCR)确定了不同Ins(1,4,5)P3R mRNA在培养细胞和小鼠来源的动物组织中的相对表达。Ins(1,4,5)P3R-I在脑和小脑中非常突出,Ins(1,4,5)P3R-II在上皮组织如肾脏以及心脏和骨骼肌中突出。Ins(1,4,5)P3R-III在所有培养细胞类型以及细胞更新率高的组织如睾丸中高度表达。免疫印迹分析证实了Ins(1,4,5)P3R-I和Ins(1,4,5)P3R-III分别在A7r5和C3H10T1/2细胞中的突出表达,并且与前一种细胞类型中Ins(1,4,5)P3诱导的Ca2+释放的较低阈值相符。对大量小鼠细胞系和组织的筛选揭示了本研究中鉴定出的Ins(1,4,5)P3R-I以及Ins(1,4,5)P3R-II和Ins(1,4,5)P3R-III亚型的存在,但与先前的报告相反,没有证据表明存在更多的亚型多样性。